Hepatocellular carcinoma: Recent trends in the United States

Gastroenterology

Volumn 127, Issue 5 SUPPL., 2004, Pages

  El Serag, Hashem B ^a,b  

^a Veterans Administration   (United States)

^b MICHAEL E DEBAKEY VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL CONSUMPTION; ASIAN; CONFERENCE PAPER; DEMOGRAPHY; DIABETES MELLITUS; GENDER; HEPATITIS C; HISPANIC; HOSPITALIZATION; HUMAN; INCIDENCE; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; METABOLIC SYNDROME X; MORTALITY; OBESITY; POPULATION RESEARCH; PRIORITY JOURNAL; RACE; RISK FACTOR; SURVIVAL; UNITED STATES;

EID: 7044231396     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.gastro.2004.09.013     Document Type: Conference Paper

References (37)

1. National Cancer Institute Surveillance, Epidemiology, and End Results (SEER) Program Public-Use CD-ROM (1973-1996) 1999 National Cancer Institure, DCPC Surveillance Program, Cancer Statistics Branch
2. World Health Organization International Classification of Diseases for Onology 1976 World Health Organization Geneva Switzerland
3. H.B. El-Serag, A.C. Mason Rising incidence of hepatocellular carcinoma in the United States N Engl J Med 340 1999 745 750
4. H.B. El-Serag, J.A. Davila, N.J. Petersen, K.A. McGlynn The continuing increase in the incidence of hepatocellular carcinoma in the United States an update Ann Intern Med 139 2003 817 823
5. M.M. Hassan, A. Frome, Y.Z. Patt, H.B. El-Serag Rising prevalence of hepatitis C virus infection among patients recently diagnosed with hepatocellular carcinoma in the United States J Clin Gastroenterol 35 2002 266 269
6. K. Kulkarni, E. Barcak, H.B. El-Serag, R. Goodgame The impact of immigration on the increasing incidence of hepatocellular carcinoma Aliment Pharmacol Ther 20 2004 445 502
7. H.B. El-Serag, J.A. Davila Is fibrolamellar carcinoma different from hepatocellular carcinoma? A US population-based study Hepatology 39 2004 798 803
8. H.B. El-Serag Epidemiology of hepatocellular carcinoma Clin Liver Dis 5 2001 87 107
9. K.A. Shea, L.E. Fleming, J.D. Wilkinson, B. Wohler-Torres, J.A. McKinnon Hepatocellular carcinoma incidence in Florida. Ethnic and racial distribution Cancer 91 2001 1046 1051
10. J.A. Davila, N.J. Petersena, H.A. Nelson, H.B. El-Serag Geographic variation within the United States in the incidence of hepatocellular carcinoma J Clin Epidemiol 56 2003 487 493
11. H.B. El-Serag, A.C. Mason, C. Key Trends in survival of patients with hepatocellular carcinoma between 1977 and 1996 in the United States Hepatology 33 2001 62 65
12. A.M. Di Bisceglie, S.E. Order, J.L. Klein, J.G. Waggoner, M.H. Sjogren, G. Kuo, M. Houghton, Q.L. Choo, J.H. Hoofnagle The role of chronic viral hepatitis in hepatocellular carcinoma in the United States Am J Gastroenterol 86 1991 335 338
13. A.M. Di Bisceglie, A.C. Lyra, M. Schwartz, R.K. Reddy, P. Martin, G. Gores, A.S. Lok, K.B. Hussain, R. Gish, D.H. Van Thiel, Z. Younossi, M. Tong, T. Hassanein, L. Balart, J. Fleckenstein, S. Flamm, A. Blei, A.S. Befeler Hepatitis C-related hepatocellular carcinoma in the United States influence of ethnic status Am J Gastroenterol 98 2003 2060 2063
14. T.J. Liang, L.J. Jeffers, K.R. Reddy, M. De Medina, I.T. Parker, H. Cheinquer, V. Idrovo, A. Rabassa, E.R. Schiff Viral pathogenesis of hepatocellular carcinoma in the United States Hepatology 18 1993 1326 1333
15. Y. Zen, K. Katayanagi, K. Tsuneyama, K. Harada, I. Araki, Y. Nakanuma Hepatocellular carcinoma arising in non-alcoholic steatohepatitis Pathol International 51 2001 127 131
16. E. Bugianesi, N. Leone, E. Vanni, G. Marchesini, F. Brunello, P. Carucci, A. Musso, P. De Paolis, L. Capussotti, M. Salizzoni, M. Rizzetto Expanding the natural history of nonalcoholic steatohepatitis from cryptogenic cirrhosis to hepatocellular carcinoma Gastroenterology 123 2002 134 140
17. J.A. Marrero, R.J. Fontana, G.L. Su, H.S. Conjeevaram, D.M. Emick, A.S. Lok NAFLD may be a common underlying liver disease in patients with hepatocellular carcinoma in the United States Hepatology 36 2002 1349 1354
18. E. Bugianesi, C. Zannoni, E. Vanni, R. Marzocchi, G. Marchesini Non-alcoholic fatty liver and insulin resistance a cause-effect relationship? Dig Liver Dis 36 2004 165 173
19. E.E. Calle, C. Rodriguez, K. Walker-Thurmond, M.J. Thun Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S adults. N Engl J Med 348 2003 1625 1638
20. S.N. Lu, T.M. Lin, C.J. Chen, J.S. Chen, Y.F. Liaw, W.Y. Chang, S.T. Hsu A case-control study of primary hepatocellular carcinoma in Taiwan Cancer 62 1988 2051 2055
21. M. Ragozzino, L.J. Melton III, C.P. Chu, P.J. Palumbo Subsequent cancer risk in the incidence cohort of Rochester, Minnesota, residents with diabetes mellitus J Chronic Dis 35 1982 13 19
22. H.O. Adami, W.H. Chow, O. Nyren, C. Berne, M.S. Linet, A. Ekbom, A. Wolk, J.K. McLaughlin, J.F. Fraumeni Jr Excess risk of primary liver cancer in patients with diabetes mellitus J Natl Cancer Inst 88 1996 1472 1477
23. C. La Vecchia, E. Negri, A. Decarli, S. Franceschi Diabetes mellitus and the risk of primary liver cancer Int J Cancer 73 1997 204 207
24. D.H. Lawson, J.M. Gray, C. McKillop, J. Clarke, F.D. Lee, R.S. Patrick Diabetes mellitus and primary hepatocellular carcinoma Q J Med 61 1986 945 955
25. M.C. Yu, M.J. Tong, S. Govindarajan, B.E. Henderson Nonviral risk factors for hepatocellular carcinoma in a low-risk population, the non-Asians of Los Angeles County, California J Natl Cancer Inst 83 1991 1820 1826
26. M.C. Yu, M.J. Tong, P. Coursaget, R.K. Ross, S. Govindarajan, B.E. Henderson Prevalence of hepatitis B and C viral markers in black and white patients with hepatocellular carcinoma in the United States J Natl Cancer Inst 82 1990 1038 1041
27. M.M. Hassan, L.Y. Hwang, C.J. Hatten, M. Swaim, D. Li, J.L. Abbruzzese, P. Beasley, Y.Z. Patt Risk factors for hepatocellular carcinoma synergism of alcohol with viral hepatitis and diabetes mellitus Hepatology 36 2002 1206 1213
28. H.B. El-Serag, P.A. Richardson, J.E. Everhart The role of diabetes in hepatocellular carcinoma a case-control study among United States Veterans Am J Gastroenterol 96 2001 2462 2467
29. H.B. El-Serag, T. Tran, J.E. Everhart Diabetes increases the risk of chronic liver disease and hepatocellular carcinoma Gastroenterology 126 2004 460 468
30. H.B. El-Serag, J.E. Everhart Improved survival after variceal hemorrhage over an 11-year period in the Department of Veterans Affairs Am J Gastroenterol 95 2000 3566 3573
31. B.F. Grant, T.S. Zobeck, R.P. Pickering Liver cirrhosis mortality in the United States. 1973-1978 1990 US Department of Health and Human Services, Alcohol, Drug Abuse, and Mental Health Administration, National Institute on Alcohol Abuse & Alcoholism
32. W.R. Kim, R.S. Brown Jr, N.A. Terrault, H. El-Serag Burden of liver disease in the United States summary of a workshop Hepatology 36 2002 227 242
33. H.B. El-Serag, A.C. Mason Risk factors for the rising rates of primary liver cancer in the United States Arch Intern Med 160 2000 3227 3230
34. J. Davila, R. Morgan, Y. Shaib, K. McGlynn, H.B. El-Serag Hepatitis C infection and the rising incidence of heptocellular carcinoma a population-based study Gastroenterology 127 2004 1372 1380
35. B. Goodgame, N.J. Shaheen, J. Galanko, H.B. El-Serag The risk of end stage liver disease and hepatocellular carcinoma among persons infected with hepatitis C virus publication bias? Am J Gastroenterol 98 2003 2535 2542
36. G.L. Armstrong, M.J. Alter, G.M. McQuillan, H.S. Margolis The past incidence of hepatitis C virus infection implications for the future burden of chronic liver disease in the United States Hepatology 31 2000 777 782
37. J.B. Wong, G.M. McQuillan, J.G. McHutchison, T. Poynard Estimating future hepatitis C morbidity, mortality, and costs in the United States Am J Public Health 90 2000 1562 1569